Music therapy improves well-being, helps to calm nerves and gives the opportunity to express various emotions, including difficult ones, shows research conducted among parents of premature babies who were in neonatology and neonatal intensive care units.
Altruism is often perceived as an impractical attitude that rarely brings tangible benefits. Meanwhile, computer simulations suggest that it may be a mechanism of human survival, the Cracow University of Technology reports.
With bacterial resistance to antibiotics being a global health challenge, scientists are looking for new ways to combat microorganisms. A tool designed to accelerate work on new antibacterial compounds has been developed by Dr. Mateusz Rzycki from the Wrocław University of Science and Technology.
Salty and polluted soils, lack of water, strong sandstorms make the areas of the dried-out Aral Sea a hostile ecosystem. Scientists from the University of Warsaw will help stabilise the desert area, restore vegetation, and retain those inhabitants who still remain there.
Tulip trees have a unique type of wood that does not fit into either category of hardwood or softwood, according to an analysis of tree evolution conducted by scientists from the Jagiellonian University and Cambridge University. The results of the research were published in the journal New Phytologist.
Institutions from Poland, Lithuania, Germany and Sweden have joined forces to reduce pollution in the Baltic Sea from dangerous fuel, munitions and other wreck remains.
Scientists from the University of Lodz are developing solutions to prevent ecosystem degradation due to global warming. One of the projects is the international undertaking 'LifeCoolCity', which aims to strengthen the adaptive capacity of cities to climate change.
Rodent teeth from over 2.5 million years ago were damaged by the caries disease, Polish palaeontologists have found. They noticed traces of the disease along with bacterial remains on a molar of a dormouse.
The results of the third phase of Lyme disease vaccine trials will most likely be available at the end of 2025, says the president of the Office for Registration of Medicinal Products. If this is confirmed, this long-awaited vaccine could be registered and available in the European Union no earlier than 2026.